Medtech company PolarCool has developed PolarCap, a medical device that actively cools down the brain in the acute phase of an injury to decrease concussion symptoms. Results from a 5-year clinical study with the device have just been published in the Journal of Neurotrauma, and PolarCool's CEO Erik Andersson stopped by the BioStock Studio to discuss the results.

Watch the interview with PolarCool's CEO Erik Andersson at biostock.se:

https://www.biostock.se/en/2022/10/polarcool-boosted-by-5-year-clinical-study-results/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

https://news.cision.com/polarcool/r/biostock--polarcool-boosted-by-5-year-clinical-study-results,c3651723

(c) 2022 Cision. All rights reserved., source Press Releases - English